ArticleHaematologica2018

Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment.

Christine Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.